Pharmafile Logo

US Department of Justice

- PMLiVE

US Supreme Court halts Purdue Pharma $6bn bankruptcy settlement

The company has been blamed for fuelling the opioid crisis by promoting its drug OxyContin

- PMLiVE

US Supreme Court asked to block Purdue Pharma bankruptcy settlement

The company has been blamed for fuelling the opioid crisis with the promotion of its drug OxyContin

Biogen Idec building

Biogen to pay $900m to settle whistleblower’s MS drug kickback lawsuit

For pursuing the case, the former employee will receive about $250m

- PMLiVE

US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan

The Sackler family will pay the amount over 18 years to victims of addiction and US states

- PMLiVE

Merck’s appeal to restore hepatitis C patent verdict against Gilead fails

US Supreme Court rejects Merck’s appeal over patent dispute verdict of $2.54bn

- PMLiVE

Purdue to pay over $8bn to settle opioid-related criminal claims

Claims relate to Purdue's involvement in fuelling the opioid addiction crisis

- PMLiVE

US charges Teva for generic drug price-fixing plot

Company maintains it has not committed any wrongdoing

- PMLiVE

US states claim Purdue Pharma owes $2.2 trillion over opioid crisis

Company faces new accusations of dishonest marketing tactics

- PMLiVE

Mallinckrodt reaches tentative $1.6bn opioid settlement

Agreement reached with a plaintiff's executive committee

- PMLiVE

As the opioid crisis grabs the headlines, the search for safe treatments continues

Indivior’s Gilles Picard charts a path to greater patient access and new therapies

Teva Pharma logo

Teva among generic drugmakers hoping to settle US antitrust probe

A number of companies are accused of colluding on drug prices

- PMLiVE

J&J proposes $4bn in cash to settle opioid crisis allegations

Upcoming federal trial puts a number of companies in the spotlight

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links